AntimetabolitesFluorouracilAntimetabolites, AntineoplasticAntineoplastic AgentsFloxuridineTetrahydrouridineTrabeculectomyMethotrexatePhosphoribosyl PyrophosphateMitomycinInosine MonophosphateLeucovorinLeukemia L1210Antineoplastic Combined Chemotherapy Protocols6-MercaptopurineDrug SynergismFolic Acid AntagonistsCytarabineDrug Screening Assays, AntitumorDeoxycytidinePurinesDihydrouracil Dehydrogenase (NADP)Cell SurvivalNeoplasmsOrganoplatinum CompoundsCisplatinTumor Cells, CulturedDrug Administration ScheduleDrug Evaluation, PreclinicalThymidylate SynthaseColorectal NeoplasmsCell CycleInfusions, IntravenousCamptothecinCell DivisionAntibiotics, AntineoplasticDoxorubicinAntineoplastic Agents, PhytogenicAdenocarcinomaCyclophosphamideColonic NeoplasmsUracilChemotherapy, AdjuvantCell LineCombined Modality TherapyEpirubicinTreatment OutcomeFluorodeoxyuridylateKineticsDose-Response Relationship, DrugSurvival AnalysisTegafurBreast NeoplasmsCell Line, TumorSemustineNeoplasm MetastasisDisease-Free SurvivalDrug Resistance, NeoplasmProdrugsPaclitaxelStomach NeoplasmsAntineoplastic Agents, AlkylatingDrug EvaluationApoptosisRectal NeoplasmsLevamisoleLeukemia P388Survival RateLiver NeoplasmsTaxoidsInfusions, Intra-ArterialLeukopeniaCarcinoma, Squamous CellStomatitisHead and Neck NeoplasmsLevoleucovorinBromouracilAntidotesFlucytosineTime FactorsChronotherapyNeutropeniaNauseaInjections, IntravenousEsophageal NeoplasmsPancreatic NeoplasmsNeoplasm TransplantationMitomycinsXenograft Model Antitumor AssaysNeoplasm StagingCell ProliferationPhospholipid EthersMucositisEllipticinesGalliumNeoadjuvant TherapyBryostatinsThiadiazinesMice, Nude